Diabetes Devices Market

Diabetes Devices Market (Product Type - Glucose Monitoring Devices (Self-monitoring Blood Glucose Meters, Blood Glucose Testing Strips, Lancets, and Continuous Glucose Monitoring Devices), Insulin Delivery Devices (Insulin Syringes, Insulin Pens, and Insulin Pumps), Diabetes Monitoring Software, and Artificial Pancreas System; Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Diabetes Clinics/Centers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

  • Rep Id : TMRGL14
  • Published On : Dec 2017
  • No. of Pages : 223
  • Category : Healthcare

1. Preface
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Diabetes Device Market

4. Market Overview
     4.1. Introduction
            4.1.1. Product Type  Definition
            4.1.2. Industry Evolution / Developments
     4.2.  Overview
     4.3. Market Dynamics
            4.4.1. Drivers
            4.4.2. Restraints
            4.4.3. Opportunity
     4.5. Global Diabetes Device Market Analysis and Forecasts, 2017–2025
     4.6. Porter’s Five Force Analysis
     4.7. Value Chain Analysis
     4.8. Estimated Number of People with Diabetes Worldwide and Per Region in 2015 and 2040 (Age 20-79 years) 
     4.9. Emerging Technologies in Diabetes Management

5. Global Diabetes Device Market Analysis and Forecasts, By Product Type  
     5.1. Introduction & Definition
     5.2. Key Findings / Developments
     5.3. Key Trends
     5.4. Market  Value  Forecast By Product Type  , 2017–2025
            5.4.1. Glucose monitoring devices
                     5.4.1.1. Self-monitoring blood glucose meters
                     5.4.1.2. Blood glucose testing strips
                     5.4.1.3. Lancets
                     5.4.1.4. Continuous glucose monitoring meters
            5.4.2. Insulin Delivery Devices
                     5.4.2.1. Insulin Syringes 
                     5.4.2.2. Insulin Pens
                     5.4.2.3. Insulin Pumps
            5.4.3. Diabetes Monitoring Software
            5.4.4. Artificial Pancreas Systems
     5.5. Product Type   Comparison Matrix
     5.6. Market Attractiveness By Product Type  

6. Global Diabetes Device Market Analysis and Forecasts, By Distribution Channel 
     6.1. Introduction & Definition
     6.2. Key Findings / Developments
     6.3. Key Trends
     6.4. Market  Value  Forecast By Distribution Channel , 2017–2025
            6.4.1. Hospital Pharmacy
            6.4.2. Retail Pharmacy
            6.4.3. Online Pharmacy
            6.4.4. Diabetes Clinics/ Centers
     6.5. Distribution Channel  Comparison Matrix
     6.6. Market Attractiveness By Distribution Channel 

7. Global Diabetes Device Market Analysis and Forecasts, By Region
     7.1. Key Findings
     7.2. Policies and Regulations
7.3. Market  Value  Forecast By Region
            7.3.1. North America 
            7.3.2. Europe 
            7.3.3. Asia Pacific  
            7.3.4. Middle East & Africa  
            7.3.5. Latin America  
     7.4. Market Attractiveness By Country/Region

8. North America Diabetes Device Market Analysis and Forecast
     8.1. Introduction
            8.1.1. Key Findings
            8.1.2. Key Trends
     8.2. Market  Value  Forecast By Product Type  , 2017–2025
            8.2.1. Glucose monitoring devices
                     8.2.1.1. Self-monitoring blood glucose meters
                     8.2.1.2. Blood glucose testing strips
                     8.2.1.3. Lancets
                     8.2.1.4. Continuous glucose monitoring meters
            8.2.2. Insulin Delivery Devices
                     8.2.2.1. Insulin Syringes 
                     8.2.2.2. Insulin Pens
                     8.2.2.3. Insulin Pumps
            8.2.3. Diabetes Monitoring Software
            8.2.4. Artificial Pancreas Systems
     8.3. Market  Value  Forecast By Distribution Channel , 2017–2025
            8.3.1. Hospital Pharmacy
            8.3.2. Retail Pharmacy
            8.3.3. Online Pharmacy
            8.3.4. Diabetes Clinics/ Centers
     8.4. Market  Value  Forecast By Country , 2017–2025
            8.4.1. U.S.
            8.4.2. Canada
     8.5. Market Attractiveness Analysis 
            8.5.1. By Product Type  
            8.5.2. By Distribution Channel 
            8.5.3. By Country

9. Europe Diabetes Device Market Analysis and Forecast
     9.1. Introduction
            9.1.1. Key Findings
            9.1.2. Key Trends
     9.2. Market  Value  Forecast By Product Type  , 2017–2025
            9.2.1. Glucose monitoring devices
                     9.2.1.1. Self-monitoring blood glucose meters
                     9.2.1.2. Blood glucose testing strips
                     9.2.1.3. Lancets
                     9.2.1.4. Continuous glucose monitoring meters
            9.2.2. Insulin Delivery Devices
                     9.2.2.1. Insulin Syringes 
                     9.2.2.2. Insulin Pens
                     9.2.2.3. Insulin Pumps
            9.2.3. Diabetes Monitoring Software
            9.2.4. Artificial Pancreas Systems
     9.3. Market  Value  Forecast By Distribution Channel , 2017–2025
            9.3.1. Hospital Pharmacy
            9.3.2. Retail Pharmacy
            9.3.3. Online Pharmacy
            9.3.4. Diabetes Clinics/ Centers
     9.4. Market  Value  Forecast By Country , 2017–2025
            9.4.1. Germany
            9.4.2. France
            9.4.3. Italy
            9.4.4. Spain
            9.4.5. U.K.
            9.4.6. Rest of Europe
     9.5. Market Attractiveness Analysis 
            9.5.1. By Product Type  
            9.5.2. By Distribution Channel 
            9.5.3. By Country

10. Asia Pacific  Diabetes Device Market Analysis and Forecast
     10.1. Introduction
            10.1.2. Key Trends
     10.2. Market  Value  Forecast By Product Type  , 2017–2025
            10.2.1. Glucose monitoring devices
                     10.2.1.1. Self-monitoring blood glucose meters
                     10.2.1.2. Blood glucose testing strips
                     10.2.1.3. Lancets
                     10.2.1.4. Continuous glucose monitoring meters
            10.2.2. Insulin Delivery Devices
                     10.2.2.1. Insulin Syringes 
                     10.2.2.2. Insulin Pens
                     10.2.2.3. Insulin Pumps
            10.2.3. Diabetes Monitoring Software
            10.2.4. Artificial Pancreas Systems
     10.3. Market  Value  Forecast By Distribution Channel , 2017–2025
            10.3.1. Hospital Pharmacy
            10.3.2. Retail Pharmacy
            10.3.3. Online Pharmacy
            10.3.4. Diabetes Clinics/ Centers
     10.4. Market  Value  Forecast By Country , 2017–2025
            10.4.1. China
            10.4.2. Japan
            10.4.3. India
            10.4.4. Australia & New Zealand
            10.4.5. Rest of Asia Pacific
     10.5. Market Attractiveness Analysis 
            10.5.1. By Product Type  
            10.5.2. By Distribution Channel 
            10.5.3. By Country

11. Middle East & Africa  Diabetes Device Market Analysis and Forecast
     11.1. Introduction
            11.1.1. Key Findings
            11.1.2. Key Trends
     11.2. Market  Value  Forecast By Product Type, 2017–2025
            11.2.1. Glucose monitoring devices
                     11.2.1.1. Self-monitoring blood glucose meters
                     11.2.1.2. Blood glucose testing strips
                     11.2.1.3. Lancets
                     11.2.1.4. Continuous glucose monitoring meters
            11.2.2. Insulin Delivery Devices
                     11.2.2.1. Insulin Syringes 
                     11.2.2.2. Insulin Pens
                     11.2.2.3. Insulin Pumps
            11.2.3. Diabetes Monitoring Software
            11.2.4. Artificial Pancreas Systems
     11.3. Market  Value  Forecast By Distribution Channel, 2017–2025
            11.3.1. Hospital Pharmacy
            11.3.2. Retail Pharmacy
            11.3.3. Online Pharmacy
            11.3.4. Diabetes Clinics/ Centers
     11.4. Market  Value  Forecast By Country, 2017–2025
            11.4.1. GCC Countries
            11.4.2. South Africa
            11.4.3. Rest of MEA
     11.5. Market Attractiveness Analysis 
            11.5.1. By Product Type  
            11.5.2. By Distribution Channel 
            11.5.3. By Country

12. Latin America  Diabetes Device Market Analysis and Forecast
     12.1. Introduction
            12.1.1. Key Findings
            12.1.2. Key Trends
     12.2. Market  Value  Forecast By Product Type, 2017–2025
            12.2.1. Glucose monitoring devices
                     12.2.1.1. Self-monitoring blood glucose meters
                     12.2.1.2. Blood glucose testing strips
                     12.2.1.3. Lancets
                     12.2.1.4. Continuous glucose monitoring meters
            12.2.2. Insulin Delivery Devices
                     12.2.2.1. Insulin Syringes 
                     12.2.2.2. Insulin Pens
                     12.2.2.3. Insulin Pumps
            12.2.3. Diabetes Monitoring Software
            12.2.4. Artificial Pancreas Systems
     12.3. Market  Value  Forecast By Distribution Channel, 2017–2025
            12.3.1. Hospital Pharmacy
            12.3.2. Retail Pharmacy
            12.3.3. Online Pharmacy
            12.3.4. Diabetes Clinics/ Centers
     12.4. Market  Value  Forecast By Country, 2017–2025
            12.4.1. Brazil
            12.4.2. Mexico
            12.4.3. Rest of Latin America
     12.5. Market Attractiveness Analysis 
            12.5.1. By Product Type  
            12.5.2. By Distribution Channel 
            12.5.3. By Country

13. Competition Landscape
     13.1. Market Player – Competition Matrix (By Tier and Size of companies)
     13.2. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
            13.2.1. Medtronic
                     13.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                     13.2.1.2. Financial Overview
                     13.2.1.3. Product Portfolio
                     13.2.1.4. SWOT Analysis
                     13.2.1.5. Strategic Overview
            13.2.2. Novo Nordisk A/S
                     13.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                     13.2.2.2. Financial Overview
                     13.2.2.3. Product Portfolio
                     13.2.2.4. SWOT Analysis
                     13.2.2.5. Strategic Overview
            13.2.3. Sanofi
                     13.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                     13.2.3.2. Financial Overview
                     13.2.3.3. Product Portfolio
                     13.2.3.4. SWOT Analysis
                     13.2.3.5. Strategic Overview
            13.2.4. Eli Lilly and Company
                     13.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                     13.2.4.2. Financial Overview
                     13.2.4.3. Product Portfolio
                     13.2.4.4. SWOT Analysis
                     13.2.4.5. Strategic Overview
            13.2.5. F. Hoffmann-La Roche Ltd.
                     13.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                     13.2.5.2. Financial Overview
                     13.2.5.3. Product Portfolio
                     13.2.5.4. SWOT Analysis
                     13.2.5.5. Strategic Overview
            13.2.6. Becton, Dickinson and Company
                     13.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                     13.2.6.2. Financial Overview
                     13.2.6.3. Product Portfolio
                     13.2.6.4. SWOT Analysis
                     13.2.6.5. Strategic Overview
            13.2.7. Tandem Diabetes Care, Inc.
                     13.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                     13.2.7.2. Financial Overview
                     13.2.7.3. Product Portfolio
                     13.2.7.4. SWOT Analysis
                     13.2.7.5. Strategic Overview
            13.2.8. Abbott Laboratories
                     13.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
                     13.2.8.2. Financial Overview
                     13.2.8.3. Product Portfolio
                     13.2.8.4. SWOT Analysis
                     13.2.8.5. Strategic Overview
            13.2.9. Cellnovo
                     13.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
                     13.2.9.2. Financial Overview
                     13.2.9.3. Product Portfolio
                     13.2.9.4. SWOT Analysis
                     13.2.9.5. Strategic Overview
            13.2.10. Insulet Corporation
                     13.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
                     13.2.10.2. Financial Overview
                     13.2.10.3. Product Portfolio
                     13.2.10.4. SWOT Analysis
                     13.2.10.5. Strategic Overview
            13.2.11. LifeScan, Inc. 
                     13.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
                     13.2.11.2. Financial Overview
                     13.2.11.3. Product Portfolio
                     13.2.11.4. SWOT Analysis
                     13.2.11.5. Strategic Overview
            13.2.12. Owen Mumford Ltd.
                     13.2.12.1. Company Overview (HQ, Business Segments, Employee Strength)
                     13.2.12.2. Financial Overview
                     13.2.12.3. Product Portfolio
                     13.2.12.4. SWOT Analysis
                     13.2.12.5. Strategic Overview

List of Tables

Table 01: Global Diabetes Devices Market Size (US$ Mn) Forecast, by Product type, 2015–2025
Table 02: Global Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type –Glucose Monitoring Devices 2015–2025
Table 03: Global Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type– Insulin Delivery Devices, 2015–2025
Table 04: Global Diabetes Devices Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 05: Global Insulin Delivery Devices Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 06: North America Diabetes Devices Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 07: North America Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 08: North America Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type –Glucose Monitoring Devices 2015–2025
Table 09: North America Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type– Insulin Delivery Devices, 2015–2025
Table 10: North America Diabetes Devices Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 11: Europe Diabetes Devices Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 12: Europe Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 13: Europe Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type –Glucose Monitoring Devices, 2015–2025
Table 14: Europe Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type – Insulin Delivery Devices, 2015–2025
Table 15: Europe Diabetes Devices Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 16: Asia Pacific Diabetes Devices Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 17: Asia Pacific Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 18: Asia Pacific Diabetes Devices Market Size (US$ Mn) Forecast, by Glucose Monitoring Devices, 2015–2025
Table 19: Asia Pacific Diabetes Devices Market Size (US$ Mn) Forecast, by Insulin Delivery Devices, 2015–2025
Table 20: Asia Pacific Diabetes Devices Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 21: Latin America Diabetes Devices Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 22: Latin America Diabetes Devices Market Size (US$ Mn) Forecast, by product type, 2015–2025
Table 23: Latin America Diabetes Devices Market Size (US$ Mn) Forecast, by Glucose Monitoring Devices, 2015–2025
Table 24: Latin America Diabetes Devices Market Size (US$ Mn) Forecast, by Insulin Delivery Devices, 2015–2025
Table 25: Latin America Diabetes Devices Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 26: Middle East & Africa Diabetes Devices Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 27: Middle East & Africa Market Size (US$ Mn) Forecast, by product type, 2015–2025
Table 28: Middle East & Africa Diabetes Devices Market Size (US$ Mn) Forecast, by Glucose Monitoring Devices, 2015–2025
Table 29: Middle East & Africa Diabetes Devices Market Size (US$ Mn) Forecast, by Insulin Delivery Devices, 2015–2025
Table 30: Middle East & Africa Diabetes Devices Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025

List of Figures

Figure 01: Diabetes Devices Market, by Product, Market Size (US$ Mn), 2016 (A)
Figure 02: Diabetes Devices Market, by Distribution Channel, Market Share, 2016 (A)
Figure 03: Global Diabetes Devices Market Size (US$ Mn) Forecast, 2015–2025
Figure 04: Revenue Share (1)
Figure 05: Revenue Share (2)
Figure 06: Estimated Number of People with Diabetes Worldwide and Per Region in 2015 and 2040 (Age 20-79 years) 
Figure 07: Global Diabetes Devices Market Value Share, by Product Type, 2016 and 2025
Figure 08: Global Diabetes Devices Market Attractiveness, by Product Type, 2017–2025
Figure 09: Global Diabetes Devices Market Value Share, by Glucose Monitoring Devices, 2017 and 2025
Figure 10: Global America Diabetes Devices Market Value Share, by Insulin Delivery Devices, 2017 and 2025
Figure 11: Global Diabetes Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Glucose Monitoring Devices, 2015–2025
Figure 12: Global Diabetes Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Insulin Delivery Devices, 2015–2025
Figure 13: Global Diabetes Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diabetes Monitoring Software, 2015–2025
Figure 14: Global Diabetes Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Artificial Pancreas System, 2015–2025
Figure 15: Global Diabetes Devices Market Value Share, by Distribution Channel, 2016 and 2025
Figure 16: Global Diabetes Devices Market Attractiveness, by Distribution Channel, 2017–2025
Figure 17: Global Diabetes Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospital Pharmacy, 2015–2025
Figure 18: Global Diabetes Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacy, 2015–2025
Figure 19: Global Diabetes Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Online Pharmacy, 2015–2025
Figure 20: Global Diabetes Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diabetes Clinics/ Centers, 2015–2025
Figure 21: Global Market Scenario by Country (1/1)
Figure 22: Global Diabetes Devices Market Value Share Analysis, by Region, 2016 and 2025
Figure 23: Global Diabetes Devices Market Attractiveness Analysis, by Region, 2017–2025
Figure 24: North America Diabetes Devices Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 25: North America Diabetes Devices Market Attractiveness Analysis, by Country, 2017–2025
Figure 26: North America Diabetes Devices Market Value Share Analysis, by Country, 2017 and 2025
Figure 27: North America Diabetes Devices Market Value Share, by Product Type, 2017 and 2025
Figure 28: North America Diabetes Devices Market Attractiveness Analysis, by Product Type, 2017–2025
Figure 29: North America Diabetes Devices Market Value Share, by Glucose Monitoring Devices, 2017 and 2025
Figure 30: North America Diabetes Devices Market Value Share, by Insulin Delivery Devices, 2017 and 2025
Figure 31: North America Diabetes Devices Market Value Share Analysis, by Distribution Channel, 2017 and 2025
Figure 32: North America Diabetes Devices Market Attractiveness Analysis, by Distribution Channel, 2017 and 2025
Figure 33: Europe Diabetes Devices Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 34: Europe Diabetes Devices Market Attractiveness Analysis, by Country, 2017–2025
Figure 35: Europe Diabetes Devices Market Value Share Analysis, by Country, 2017 and 2025
Figure 36: Europe Diabetes Devices Market Value Share, by Product Type, 2017 and 2025
Figure 37: Europe Diabetes Devices Market Attractiveness Analysis, by Product Type, 2017–2025
Figure 38: Europe Diabetes Devices Market Value Share, by Glucose Monitoring Devices, 2017 and 2025
Figure 39: Europe Diabetes Devices Market Value Share, by Insulin Delivery Devices, 2017–2025
Figure 40: Europe Diabetes Devices Market Value Share Analysis, by Distribution Channel, 2017 and 2025
Figure 41: Europe Diabetes Devices Market Attractiveness Analysis, by Distribution Channel, 2017 and 2025
Figure 42: Asia Pacific Diabetes Devices Market Size (US$ Mn) Forecast, and Y-o-Y Growth (%) Forecast, by region, 2015–2025
Figure 43: Asia Pacific Diabetes Devices Market Attractiveness Analysis, by Country
Figure 44: Asia Pacific Diabetes Devices  Market Value Share Analysis, by Country, 2017 and 2025
Figure 45: Asia Pacific  Diabetes Devices Market Value Share Analysis, by Product type 2017 and 2025
Figure 46: Asia Pacific Diabetes Devices Market Attractiveness Analysis, by product type
Figure 47: Asia Pacific Diabetes Devices Market Value Share, by Glucose Monitoring Devices, 2017 and 2025
Figure 48: Asia Pacific Diabetes Devices Market Value Share, by Insulin Delivery Devices, 2017–2025
Figure 49: APAC Diabetes Devices Market Value Share Analysis, by Distribution Channel, 2017 and 2025
Figure 50: Asia Pacific Diabetes Devices Market Attractiveness Analysis, by Distribution Channel, 2017 and 2025
Figure 51: Latin America Diabetes Devices Market Size (US$ Mn) Forecast, and Y-o-Y Growth (%) Forecast, by region, 2015–2025
Figure 52: Latin America Diabetes Devices Market Attractiveness Analysis, by Country
Figure 53: Latin America Market Value Share Analysis, by Country, 2017 and 2025
Figure 54: Latin America Market Value Share Analysis, by Product type 2017 and 2025
Figure 55: Latin America Diabetes Devices Market Attractiveness Analysis, by product type
Figure 56: Latin America Diabetes Devices Market Value Share, by Glucose Monitoring Devices,  2017 and 2025
Figure 57: Latin America Diabetes Devices Market Value Share, by Insulin Delivery Devices, 2017–2025
Figure 58: Latin America Diabetes Devices Market Value Share Analysis, by Distribution Channel, 2017 and 2025
Figure 59: Latin America Diabetes Devices Market Attractiveness Analysis, by Distribution Channel, 2017 and 2025
Figure 60: Middle East & Africa Diabetes Devices Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast 2017-2015
Figure 61: Middle East & Africa Diabetes Devices Market Attractiveness Analysis, by Country, 2017-2025
Figure 62: Middle East & Africa Market Value Share Analysis, by Country, 2017 and 2025
Figure 63: Middle East & Africa Market Value Share Analysis, by Product type 2017 and 2025
Figure 64: Middle Diabetes Devices Market Attractiveness Analysis, by product type
Figure 65: Middle East & Africa Diabetes Devices Market Value Share, by Glucose Monitoring Devices, 2017 and 2025
Figure 66: Middle East & Africa Diabetes Devices Market Value Share, by Insulin Delivery Devices, 2017–2025
Figure 67: MEA Diabetes Devices Market Value Share Analysis, by Distribution Channel, 2017 and 2025
Figure 68: MEA Diabetes Devices Market Attractiveness Analysis, by Distribution Channel, 2017 and 2025
Figure 69: Medtronic, Revenue (US$ Bn) & Y-o-Y Growth (%), 2014–2017
Figure 70: Medtronic, R&D Intensity and Sales & Marketing Intensity (%) – Company Level or Segment Level, 2015–2016
Figure 71: Medtronic, Breakdown of Net Sales, By Region 2017
Figure 72: Medtronic, Breakdown of Net Sales, by Business Segments, 2017
Figure 73: Novo Nordisk A/S, Revenue (US$ Bn) & Y-o-Y Growth (%), 2013–2016
Figure 74: Novo Nordisk A/S, R&D Intensity and Sales & Marketing Intensity (%), 2015–2016
Figure 75: Novo Nordisk A/S, Breakdown of Net Sales, By Region 2016
Figure 76: Novo Nordisk A/S, Breakdown of Net Sales, by Business Segments, 2016
Figure 77: Sanofi, Revenue (US$ Bn) & Y-o-Y Growth (%), 2013–2016
Figure 78: Sanofi, R&D Intensity and Sales & Marketing Intensity (US$ Bn), 2015–2016
Figure 79: Sanofi, Breakdown of Net Sales, By Region 2016
Figure 80: Sanofi, Breakdown of Net Sales, by Business Segments, 2016
Figure 81: Eli Lilly and Company, Revenue (US$ Bn) & Y-o-Y Growth (%), 2013–2016
Figure 82: Eli Lilly and Company, R&D Intensity and Sales & Marketing Intensity – Company Level, 2015–2016
Figure 83: Eli Lilly and Company, Breakdown of Net Sales, By Region 2017
Figure 84: Eli Lilly and Company, Breakdown of Net Sales, by Endocrinology Segment, 2016
Figure 85: F. Hoffmann-La Roche Ltd., Revenue (US$ Bn) & Y-o-Y Growth (%), 2013–2016
Figure 86: F. Hoffmann-La Roche Ltd., R&D Intensity (US$ Bn), 2015–2016
Figure 87: F. Hoffmann-La Roche Ltd., Breakdown of Net Sales of Diabetes Care Business Area, By Region 2016
Figure 88: F. Hoffmann-La Roche Ltd., Breakdown of Net Sales, by Diagnostic Division, 2016
Figure 89: Becton, Dickinson and Company, Revenue (US$ Bn) & Y-o-Y Growth (%), 2013–2016
Figure 90: Becton, Dickinson and Company, R&D Expense (US$ Mn), 2015–2016
Figure 91: Becton, Dickinson and Company, Breakdown of Net Sales, By Region 2016
Figure 92: Becton, Dickinson and Company, Breakdown of Net Sales, by BD Medical Business segment, 2016
Figure 93: Tandem Diabetes Care, Inc., Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
Figure 94: Tandem Diabetes Care, Inc., R&D Expense (US$ Mn), 2015–2016
Figure 95: Abbott Laboratories, Revenue (US$ Bn) & Y-o-Y Growth (%), 2013–2016
Figure 96: Abbott Laboratories, R&D Intensity and Sales & Marketing Intensity – Company Level, 2015–2016
Figure 97: Abbott Laboratories, Breakdown of Net Sales, By Region 2016
Figure 98: Abbott Laboratories, Breakdown of Net Sales, by Business Segment, 2016
Figure 99: Cellnovo, Revenue (US$ Mn) & Y-o-Y Growth (%), 2014–2016
Figure 100: Insulet Corporation, Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
Figure 101: Insulet Corporation, R&D Intensity and Sales & Marketing Intensity (US$ Mn) – Company Level, 2015–2016
Figure 102: Insulet Corporation, Breakdown of Net Sales, by Region, 2016
Figure 103: Insulet Corporation, Breakdown of Net Sales, By Business Segments 2016
Figure 104: LifeScan, Inc., Concerned Company Revenue (US$ Bn) & Y-o-Y Growth (%), 2013–2016
Figure 105: LifeScan, Inc., R&D Intensity and Sales & Marketing Intensity – Company Level, 2015–2016
Figure 106: LifeScan, Inc., Breakdown of Net Sales, By Region (Company Level), 2016
Figure 107: LifeScan, Inc., Breakdown of Net Sales, (By Business And Business Segment Level), 2016